Thorasys develops respiratory diagnostic equipment for clinical use, centered on its proprietary Airwave Oscillometry System (AOS®). The AOS platform provides non‑invasive oscillometry measurements that help clinicians assess lung function more quickly and accurately than traditional spirometry, supporting early detection and monitoring of respiratory disorders.
Funding
Funding not disclosed
3OMFounders
Product
Problem
Traditional lung function testing relies on spirometry, which can be effort‑dependent, uncomfortable for patients, and may miss early signs of respiratory disease. Limited accessibility to precise, non‑invasive diagnostics hampers timely detection and monitoring of conditions such as asthma, COPD, and interstitial lung disease.
Solution
Thorasys offers the Airwave Oscillometry System (AOS®), an FDA‑cleared, dedicated device that performs non‑invasive oscillometry to assess respiratory mechanics quickly and accurately. The system delivers high‑resolution measurements of airway resistance and reactance without requiring forced breathing maneuvers, reducing patient effort and improving test reliability. Results are generated in real time and can be integrated into existing clinical workflows, enabling clinicians to detect early functional changes and track disease progression during routine visits.
Target Audience
Primary customers are pulmonologists, respiratory therapists, and primary‑care clinics that require precise, patient‑friendly lung function testing for diagnosis and longitudinal monitoring of respiratory disorders.
Features
- Dedicated oscillometry hardware optimized for clinical environments with FDA clearance
- Effort‑independent measurement of airway resistance and reactance across multiple frequencies
- Rapid test protocol delivering results in seconds, suitable for high‑throughput settings
- Automated data analysis and reporting tools that integrate with electronic health record systems
- Built‑in quality control algorithms to ensure consistent, reproducible measurements